Why did Trump's tariffs push some companies closer to default?
How will Union Pacific's potential Norfolk Southern merger impact railroads?
What caused Netflix's latest earnings surge despite stock dip?
Why is Coca-Cola considering cane sugar over corn syrup?
How does the GENIUS Act affect cryptocurrency regulation?
What are the risks if Trump fires Fed Chair Powell?
Why did Meta settle the $8 billion Facebook privacy lawsuit?
Arcutis Stock Awaits Next Move In A Base; Its Skin Drug Sales Grew 196%
investors.com/research/arcutis-arqt-stock-ibd-50/?src=A00220
Arcutis Biotherapeutics (ARQT) stock is inching higher in a base after the biotech has been trending sideways. This IBD 50 Growth Stocks To Watch pick for Thursday has seen growing demand for its centerpiece skin disorder drug. Further, the biotech company has shown an improving bottom…
This story appeared on investors.com, 2025-07-17 16:25:39.